The side effects of the Sputnik V COVID-19 vaccine

May 10, 2021 by

The side effects of the Sputnik V COVID-19 vaccine

Article provide by Francis Dunn, Miami, FL

The Sputnik V covid vaccine was developed by the Gamaleya National Center of Epidemiology and Microbiology in Russia and was the first COVID-19 vaccine to be authorized. Sputnik V has been approved by over 64 counties. Although the vaccine is safe and effective, some concerns have been raised over clinical trials.

The vaccine is a two-part adenovirus viral vector vaccine and shows an efficacy rate of 91.6%. Adenoviruses are a virus that is associated with the common cold and other illnesses. This virus delivers the DNA instructions to produce the protein spike of the SARS-CoV-2 virus in the body. The process triggers the production of antibodies against the spike, rearing the immune system for the infection.

The vaccine includes 2 doses, each dose is a different type of adenovirus. The first dose includes a type-26 (Ad26) and the second a type-5 (Ad5). Two different doses are offered to lower the body from developing antibodies against the adenovirus, making the second dose ineffective.

According to trials conducted in early 2021, the vaccine has displayed the following common side effects:  

flu-like symptoms



injection-site reactions

Scientists however have presented mixed responses with some noting the lack of transparency and others questioning how the data has been interpreted. Scientists have also warned that including Ad5 in vaccines is dangerous as they can risk the increase of HIV acquisition. However, further research is needed to confirm this claim.

Nevertheless, for most people, the vaccine will be effective and involve mild side effects, while those with weakened immune systems can face added risks.

  "Francis Dunn Miami Florida"
Francis Dunn Miami Florida

Francis Dunn is from Miami FloridaFrancis William Dunn has spent the last twenty-five years working within the healthcare industry to improve corporate strategy and product development. He is the VP and co-founder of Medsite, Inc., a successful company that was later sold to WebMD. Francis Dunn understands how to be a successful leader and is often called upon for speaking engagements. His expertise in managing enterprise accounts continues to drive overall revenue for past employers.

Related Posts


Share This